off label glp 1 GLP‑1 Off‑Label Counseling Tips for Clinicians FDA Says to Drop Suicide

Description

In a discussion about the physician survey, the President of Omada Health, Wei-Li Shao, told Fierce Healthcare that, We believe that the decision to start, stop, or continue a GLP-1 should be made in the medical home between the patient and their primary care physician. The concept of the medical home has been defined by the American Academy of Pediatrics as, An approach to providing comprehensive and high quality primary care.that is accessible, family-centered, continuous, comprehensive, coordinated, compassionate, and culturally effective. AAP also notes that a medical home, is not a building or place, extending beyond the walls of a clinical practice.A medical home builds partnerships with clinical specialists, families and community resources

Product Specification: This poster is 20.5" x 28.5" Front and back sided are laminated Quality printing in full color

Tirzepatide (trade name Mounjaro) is a new glucose-lowering medicine in the incretin family which, to date, has included the glucagon-like peptide-1

The presence of diabetes promotes the progression of simple fatty liver to non-alcoholic steatohepatitis (NASH) and cirrhosis, and the presence of NAFLD increases the risk of diabetic complications